Extreme sleep durations and increased C-reactive protein: Effects of sex and ethnoracial group

Sleep

Volumn 36, Issue 5, 2013, Pages 769-779

  Grandner, Michael A ^a   Buxton, Orfeu M ^b,c   Jackson, Nicholas ^a   Sands Lincoln, Megan ^d   Pandey, Abhishek ^e   Jean Louis, Girardin ^e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d ELSEVIER MASSON   (France)

^e SUNY Downstate Medical Center   (United States)

Author keywords

C reactive protein; Cardiovascular disease; Epidemiology; Inflammation; Sleep duration

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; ASIAN; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; HEALTH SURVEY; HISPANIC; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; SLEEP TIME;

C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASE; EPIDEMIOLOGY; INFLAMMATION; SLEEP DURATION;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; SELF REPORT; SEX FACTORS; SLEEP DISORDERS; UNITED STATES;

EID: 84877145088     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.2646     Document Type: Article

References (71)

1. Colten HR, Altevogt BM, Institute of Medicine Committee on Sleep Medicine and Research. Sleep disorders and sleep deprivation: an unmet public health problem. Washington, DC: Institute of Medicine, National Academies Press, 2006.
2. Ulmer C, Wolman DM, Johns MME, Institute of Medicine Committee on Optimizing Graduate Medical Trainee (Resident) Hours and Work Schedules to Improve Patient Safety. Resident duty hours: Enhancing sleep, supervision, and safety. Washington, DC: National Academies Press, 2009.
3. Office of Disease Prevention and Health Promotion. Healthy People 2020 Objective Topic Areas. Washington, DC: US Department of Health and Human Services, 2011.
4. Besedovsky L, Lange T, Born J. Sleep and immune function. Pflugers Arch 2012; 463: 121-37.
5. Illi J, Miaskowski C, Cooper B., et al Association between pro- and an-ti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression. Cytokine 2012; 58: 437-47.
6. Zielinski MR, Davis JM, Fadel J.R., Youngstedt SD Influence of chronic moderate sleep restriction and exercise on inflammation and carcinogen-esis in mice. Brain Behav Immun 2012; 26: 672-9.
7. Wisor JP, Schmidt MA, Clegern WC Evidence for neuroinflammatory and microglial changes in the cerebral response to sleep loss. Sleep 2011; 34: 261-72.
8. Aldabal L, Bahammam AS Metabolic, endocrine, and immune consequences of sleep deprivation. Open Respir Med J 2011; 5: 31-43.
9. Irwin MR, Carrillo C, Olmstead R. Sleep loss activates cellular markers of inflammation: sex differences. Brain Behav Immun 2010; 24: 54-7.
10. Matthews KA, Zheng H, Kravitz H.M., et al Are inflammatory and coagulation biomarkers related to sleep characteristics in mid-life women?: Study of Women's Health Across the Nation Sleep Study. Sleep 2010; 33: 1649-55.
11. Mullington JM, Simpson NS, Meier-Ewert HK, Haack M. Sleep loss and inflammation. Best Pract Res Clin Endocrinol Metab 2010; 24: 775-84.
12. Mullington JM, Haack M, Toth M., Serrador JM, Meier-Ewert HK. Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Prog Cardiovasc Dis 2009; 51: 294-302.
13. Haack M, Sanchez E, Mullington JM Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep 2007; 30: 1145-52.
14. Meier-Ewert H.K., Ridker PM, Rifai N, et al Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004; 43: 678-83.
15. Faraut B, Boudjeltia KZ, Vanhamme L, Kerkhofs M. Immune, inflamma-tory and cardiovascular consequences of sleep restriction and recovery. Sleep Med Rev 2012; 16: 137-49.
16. Miller MA. Association of inflammatory markers with cardiovascular risk and sleepiness. J Clin Sleep Med 2011; 7: S31-3.
17. Lam JC, Ip MS Sleep and the metabolic syndrome. Indian J Med Res 2010; 131: 206-16.
18. Hirschfield GM, Pepys MB C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM 2003; 96: 793-807.
19. van Leeuwen W.M., Lehto M, Karisola P., et al Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflam-matory responses through IL-17 and CRP. PLoS ONE 2009; 4: e4589.
20. Martinez-Gomez D., Eisenmann JC, Gomez-Martinez S, et al Sleep duration and emerging cardiometabolic risk markers in adolescents. The AFI-NOS study. Sleep Med 2011; 12: 997-1002.
21. Patel SR, Zhu X, Storfer-Isser A, et al Sleep duration and biomarkers of inflammation. Sleep 2009; 32: 200-4.
22. Taheri S, Austin D, Lin L., Nieto FJ, Young T, Mignot E. Correlates of serum C-reactive protein (CRP)-no association with sleep duration or sleep disordered breathing. Sleep 2007; 30: 991-6.
23. Tuomilehto H, Peltonen M, Partinen M., et al Sleep duration, lifestyle intervention and incidence of type 2 diabetes in impaired glucose tolerance. The Finnish Diabetes Prevention Study. Diabetes Care 2009; 32: 1965-71.
24. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813-8.
25. Pradhan AD, Manson JE, Rifai N, Buring J.E., Ridker PM C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327-34.
26. Wee CC, Mukamal KJ, Huang A, Davis R.B., McCarthy EP, Mittleman MA Obesity and C-reactive protein levels among white, black, and hispanic US adults. Obesity (Silver Spring) 2008; 16: 875-80.
27. Ford ES, Giles WH, Myers G.L., Mannino DM Population distribution of high-sensitivity C-reactive protein among US men: findings from National Health and Nutrition Examination Survey 1999-2000. Clin Chem 2003; 49: 686-90.
28. Matthews KA, Sowers MF, Derby C.A., et al Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation (SWAN). Am Heart J 2005; 149: 1066-73.
29. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey Data. U.S. Department of Health and Human Services. Hyattsville, MD: National Center for Health Statistics, 2008.
30. Centers for Disease Control and Prevention. NHANES Laboratory Procedure Manual: C-Reactive Protein. Hyattsville, MD: US Department of Health and Human Services, 2007.
31. Centers for Disease Control and Prevention. Analytic and Reporting Guidelines: The National Health and Nutrition Examination Survey (NHANES). Hyattsville, MD: National Center for Health Statistics, 2006.
32. Miller MA, Kandala NB, Kivimaki M, et al Gender differences in the cross-sectional relationships between sleep duration and markers of in-flammation: Whitehall II study. Sleep 2009; 32: 857-64.
33. Suarez EC. Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. Brain Behav Immun 2008; 22: 960-8.
34. Opp MR. Sleeping to fuel the immune system: mammalian sleep and resistance to parasites. BMC Evol Biol 2009; 9: 8.
35. Williams CJ, Hu FB, Patel S.R., Mantzoros CS Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with type 2 diabetes. Diabetes Care 2007; 30: 1233-40.
36. Troxel WM, Buysse DJ, Matthews K.A., et al Sleep symptoms predict the development of the metabolic syndrome. Sleep 2010; 33: 1633-40.
37. Cappuccio FP, Stranges S, Kandala N.B., et al Gender-specific associations of short sleep duration with prevalent and incident hypertension: the Whitehall II Study. Hypertension 2007; 50: 693-700.
38. Newman AB, Spiekerman CF, Enright P, et al Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group. J Am Geriatr Soc 2000; 48: 115-23.
39. Gaskins AJ, Wilchesky M, Mumford S.L., et al Endogenous reproductive hormones and C-reactive protein across the menstrual cycle: the BioCycle Study. Am J Epidemiol 2012; 175: 423-31.
40. Ridker PM, Hennekens CH, Rifai N, Buring J.E., Manson JE Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 1999; 100: 713-6.
41. Villaneuva AT, Buchanan PR, Yee B.J., Grunstein RR Ethnicity and obstructive sleep apnoea. Sleep Med Rev 2005; 9: 419-36.
42. Kurian AK, Cardarelli KM Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. Ethn Dis 2007; 17: 143-52.
43. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998; 22: 1164-71.
44. Mensah GA, Mokdad AH, Ford E.S., Greenlund KJ, Croft JB State of disparities in cardiovascular health in the United States. Circulation 2005; 111: 1233-41.
45. Mensah GA. Eliminating disparities in cardiovascular health: six strategic imperatives and a framework for action. Circulation 2005; 111: 1332-6.
46. Chien KL, Chen PC, Hsu H.C., et al Habitual sleep duration and insomnia and the risk of cardiovascular events and all-cause death: Report from a community-based cohort. Sleep 2010; 33: 177-84.
47. Dowd JB, Goldman N, Weinstein M. Sleep duration, sleep quality, and biomarkers of inflammation in a Taiwanese population. Ann Epidemiol 2011; 21: 799-806.
48. Lauderdale DS, Knutson KL, Yan L.L., Liu K., Rathouz PJ Self-reported and measured sleep duration: how similar are they? Epidemiology 2008; 19: 838-45.
49. Patel SR, Malhotra A, Gao X., Hu FB, Neuman MI, Fawzi WW A prospective study of sleep duration and pneumonia risk in women. Sleep 2012; 35: 97-101.
50. Patel SR, Blackwell T, Ancoli-Israel S, Stone K.L., Osteoporotic rractures in men-Mr OSRG. Sleep characteristics of self-reported long sleepers. Sleep 2012; 35: 641-8.
51. Bergman RN. A better index of body adiposity. Obesity (Silver Spring) 2012; 20: 1135.
52. Bergman RN, Stefanovski D, Buchanan T.A., et al A better index of body adiposity. Obesity (Silver Spring) 2011; 19: 1083-9.
53. Lorenz MW, Karbstein P, Markus H.S., Sitzer M. High-sensitivity Creactive protein is not associated with carotid intima-media progression: the carotid atherosclerosis progression study. Stroke 2007; 38: 1774-9.
54. Ridker PM, Hennekens CH, Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.
55. Blake GJ, Rifai N, Buring J.E., Ridker PM Blood pressure, Creactive protein, and risk of future cardiovascular events. Circulation 2003; 108: 2993-9.
56. Cao JJ, Thach C, Manolio T.A., et al C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation 2003; 108: 166-70.
57. Curb JD, Abbott RD, Rodriguez B.L., et al C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 2003; 107: 2016-20.
58. Koenig W, Lowel H, Baumert J., Meisinger C. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation 2004; 109: 1349-53.
59. Danesh J, Wheeler JG, Hirschfield G.M., et al C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 1387-97.
60. Tanne D, Benderly M, Goldbourt U., et al C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease. Stroke 2006; 37: 1720-4.
61. Bos MJ, Schipper CM, Koudstaal P.J., Witteman JC, Hofman A, Breteler MM High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation 2006; 114: 1591-8.
62. Shlipak MG, Fried LF, Crump C, et al Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003; 107: 87-92.
63. Stuveling EM, Hillege HL, Bakker S.J., Gans RO, De Jong PE, De Zeeuw D. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 2003; 63: 654-61.
64. Fox ER, Benjamin EJ, Sarpong D.F., et al The relation of C-reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study. BMC Nephrol 2010; 11: 1.
65. Galarraga B, Khan F, Kumar P., Pullar T, Belch JJ C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis. Rheumatology (Oxford) 2008; 47: 1780-4.
66. Menefee LA, Cohen MJ, Anderson W.R., Doghramji K., Frank ED, Lee H. Sleep disturbance and nonmalignant chronic pain: a comprehensive review of the literature. Pain Med 2000; 1: 156-72.
67. Bloom BJ, Owens JA, McGuinn M, Nobile C., Schaeffer L, Alario AJ Sleep and its relationship to pain, dysfunction, and disease activity in juvenile rheumatoid arthritis. J Rheumatol 2002; 29: 169-73.
68. Schubert C, Hong S, Natarajan L., Mills PJ, Dimsdale JE The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun 2007; 21: 413-27.
69. Otterness IG. The value of C-reactive protein measurement in rheumatoid arthritis. Semin Arthritis Rheum 1994; 24: 91-104.
70. Shearer WT, Reuben JM, Mullington J.M., et al Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol 2001; 107: 165-70.
71. Vgontzas AN, Zoumakis E, Bixler E.O., et al Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 2004; 89: 2119-26.